Global K-Link H Exporter from India to Washington, USA, Zimbabwe & New Zealand
City Drug Exporters specializes in exporting K-Link H from India to international markets including Washington, USA, Zimbabwe, and New Zealand. We provide dependable supply solutions for pharmaceutical wholesalers, distributors, pharmacies, and healthcare procurement companies.
K-Link H is a sterile, preservative-free Riboflavin-5-Phosphate (Vitamin B2) ophthalmic solution used exclusively by ophthalmologists. It is primarily applied as a photosensitizer in Corneal Collagen Cross-Linking (CXL) procedures to strengthen the cornea, halt disease progression, and improve vision.
Primary Clinical Uses : K-Link H is officially indicated for the following ophthalmic conditions:
Keratoconus: Slows down or halts the progression of mild to moderate progressive keratoconus (a condition where the cornea thins and bulges into a cone shape).
Corneal Ectasia: Treats post-LASIK ectasia and pellucid marginal degeneration .
Other Conditions: Aids in the management of infectious keratitis, bullous keratopathy, and progressive hyperopia following radial keratotomy
City Drug House Exporters provides:
Bulk supply for hospitals & distributors
Export to USA. Washington, INDIA
Regulatory documents (COA, MSDS, etc.)
Competitive pricing & reliable logistics
Contact for More Information :
📞 Contact City drug House Exporters from India
🌐 Websites:
https://www.citydrugexporters.com
📧 Email: citydrug123@gmail.com
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 WhatsApp: +91 9975390171
City Drug Exporters specializes in exporting K-Link H from India to international markets including Washington, USA, Zimbabwe, and New Zealand. We provide dependable supply solutions for pharmaceutical wholesalers, distributors, pharmacies, and healthcare procurement companies.
K-Link H is a sterile, preservative-free Riboflavin-5-Phosphate (Vitamin B2) ophthalmic solution used exclusively by ophthalmologists. It is primarily applied as a photosensitizer in Corneal Collagen Cross-Linking (CXL) procedures to strengthen the cornea, halt disease progression, and improve vision.
Primary Clinical Uses : K-Link H is officially indicated for the following ophthalmic conditions:
Keratoconus: Slows down or halts the progression of mild to moderate progressive keratoconus (a condition where the cornea thins and bulges into a cone shape).
Corneal Ectasia: Treats post-LASIK ectasia and pellucid marginal degeneration .
Other Conditions: Aids in the management of infectious keratitis, bullous keratopathy, and progressive hyperopia following radial keratotomy
City Drug House Exporters provides:
Bulk supply for hospitals & distributors
Export to USA. Washington, INDIA
Regulatory documents (COA, MSDS, etc.)
Competitive pricing & reliable logistics
Contact for More Information :
📞 Contact City drug House Exporters from India
🌐 Websites:
https://www.citydrugexporters.com
📧 Email: citydrug123@gmail.com
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 WhatsApp: +91 9975390171
Keywords
